Immucell ICCC
NASDAQ ICCC
$10.45 -0.06 (-0.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Immucell (ICCC) EV to EBIT (2012 - 2026)

Updated

Immucell's EV to EBIT came in at 33.41 for Q2 2026, up 1.7% from 32.86 a year earlier.

Analysis

Immucell (ICCC) EV to EBIT (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Immucell reported EV to EBIT of 27.86, up 7.8% year-over-year; for FY2025, it was 31.42.

  • Going back by year, EV to EBIT was 201.06 in FY2021.
  • The Q2 2026 figure represents the highest quarterly EV to EBIT since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Immucell 94.41 Mn 71.86 Mn 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.41
Dec 31, 2025 31.42
Sep 30, 2025 22.61
Jun 30, 2025 32.86
Jun 30, 2022 152.88
Mar 31, 2022 52.30
Dec 31, 2021 201.06
Sep 30, 2017 105.34
Jun 30, 2017 37.93
Mar 31, 2017 17.65
Dec 31, 2016 20.46
Sep 30, 2016 22.61
Jun 30, 2016 10.23
Mar 31, 2016 9.05
Dec 31, 2015 8.01
Sep 30, 2015 6.45
Jun 30, 2015 15.76
Mar 31, 2015 24.69
Sep 30, 2013 42.41
Jun 30, 2013 20.51
API Access

Immucell EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ICCC&period=max&api_key=YOUR_API_KEY